Quick Links
Site Partners: UW Medicine

adult diagnosis type 1 diabetes Tag

16 Apr

TrialNet is testing rituximab-pvvr and abatacept, one after the other, to learn if using both treatments extend insulin production in people (ages 8-45) who were newly diagnosed with type 1 diabetes (T1D). Each therapy has a history of safety and effectiveness. Rituximab-pvvr is FDA-approved to...

08:26 / Diabetes
11 Aug

For people age 12 – 35 years who have been diagnosed with type 1 diabetes in the past 3 months, this study tests two JAK inhibitors (abrocitinib and ritlecitinib) to see if either or both can preserve insulin production. TrialNet researchers are testing two different JAK...

08:29 / Active Studies / Diabetes

SITE PARTNERS
uw-footer